9 - 10 February 2022, Virtual Conference.The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry's leading role in developing vaccines against COVID-19 in response to the global pandemic. This year's conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.
The 2022 agenda will explore innovations in novel and targeted delivery, RNAi innovations and antisense oligonucleotide therapeutics. Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of RNA with case studies on the treatment of cardiovascular disease, neurological diseases, and oncology.
Join RNA Therapeutics 2022 in February 2022, as SMi's 13th annual Conference brings together industry experts from leading RNA therapeutics companies to gain an expert and holistic view on the latest developments of the industry.
Benefits of attending
- Explore how mRNA vaccines have led the way in the response against COVID-19 and key takeaways for the industry
- Understand the potential of RNAi and antisense oligonucleotides for the treatment of cardiovascular and neurological diseases
- Delve into the latest innovations in novel RNA delivery and target specificity
- Engage in the growing advances and development of RNA tools for vaccines and anti-infectives.
For further information and to register, please visit:
http://www.therapeutics-rna.com
About SMi Group
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.